Researcher.Life Logo

Blood Research : Impact Factor & More

eISSN: 2288-0011pISSN: 2287-979X

Key Metrics

CiteScore
2.1
H-Index
29
SJR
Q3Hematology
SNIP
0.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Blood Research

Blood Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher KOREAN SOC HEMATOLOGY
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2013
Website URLVisit website
View less

Planning to publish in Blood Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Blood Research

A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy.
  • 19 May 2026
  • Blood research
Dynamic, anthracycline-induced chromatin alterations enable ALDH1 expression as a mechanism of inducible leukemia resistance development.
  • 13 May 2026
  • Blood research
Exploring CD79b, LC3, and TERT expression in NON-GCB DLBCL: markers associated with Rituximab-Cyclophosphamide-Doxorubicin-Vincristin-Prednisone treatment response
  • 11 May 2026
  • Blood Research
Enlarged splenic volume predicts poor survival and is associated with inflammatory imbalance in patients with diffuse large B-cell lymphoma.
  • 8 May 2026
  • Blood research
Deregulation of stemness and senescence genes in bone marrow mesenchymal stem cells of multiple myeloma: implications for therapeutic approaches.
  • 7 May 2026
  • Blood research
Checkpoint inhibitor-induced hematologic immune-related adverse events and their association with disease recurrence in hematolymphoid malignancies: a clinical perspective.
  • 6 May 2026
  • Blood research
A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy.
  • 19 May 2026
  • Blood research
Dynamic, anthracycline-induced chromatin alterations enable ALDH1 expression as a mechanism of inducible leukemia resistance development.
  • 13 May 2026
  • Blood research
Exploring CD79b, LC3, and TERT expression in NON-GCB DLBCL: markers associated with Rituximab-Cyclophosphamide-Doxorubicin-Vincristin-Prednisone treatment response
  • 11 May 2026
  • Blood Research
Enlarged splenic volume predicts poor survival and is associated with inflammatory imbalance in patients with diffuse large B-cell lymphoma.
  • 8 May 2026
  • Blood research
Deregulation of stemness and senescence genes in bone marrow mesenchymal stem cells of multiple myeloma: implications for therapeutic approaches.
  • 7 May 2026
  • Blood research
Checkpoint inhibitor-induced hematologic immune-related adverse events and their association with disease recurrence in hematolymphoid malignancies: a clinical perspective.
  • 6 May 2026
  • Blood research

FAQs on Blood Research